Developing and Testing the Effectiveness of Smart Healthcare Assisted Individualized Symptom Management Education and Home-based Exercise on Frailty, Treatment-related Adverse Events and Quality of Life in Advanced Gastric Cancer Patients Receiving Immunotherapy

Official record

Identifier

NCT07732543

Recruiting locations

Locations are not included in the offline baseline for this record. Open the official record to see the current site list.

Interventions studied

AI-ISME&HE

Lead sponsor

Taipei Veterans General Hospital, Taiwan

Target enrolment

110 participants

Study type

INTERVENTIONAL

Phase

Not applicable

Status

Not yet recruiting

First posted

Jul 29, 2026

Last updated on the registry

Jul 29, 2026

Age

18 Years

Sex

ALL

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

1. age ≥18 years
2. diagnosed as AGC (TNM: T2\~T4, N\>0, Any M, Stage: III\~IV, or unresectable GC)
3. scheduled to receive the first cycle of immunotherapy
4. willingness to provide written informed consent after receiving a full explanation of the study

Exclusion Criteria:

1. a diagnosis of another type of cancer within the past five years
2. inability to communicate clearly
3. a diagnosis of dementia
4. acute pulmonary embolism
5. acute myocardial infarction
6. extremity bone fracture within the past three months
7. bone metastasis